Jane Street’s China Pharma Holdings CPHI Stock Holding History

Jane Street’s Portfolio CPHI Stock Details CPHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$23.3K	Buy	35,479 +21,593	+156%	+$22.8K	﹤0.01%	11248
2026 Q2	$9.17K	Buy	+13,886	New	+$9.7K	﹤0.01%	11313
2019 Q1	–	Sell	-81	Closed	-$10K	–	5066
2018 Q4	$10K	Buy	+81	New	+$11.8K	﹤0.01%	4821

Other funds holding CPHI

Sabby Management Miami Beach, Florida $9.02M AUM 74.48% 1-Year Est. Return

StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $50.1B AUM 35.17% 1-Year Est. Return

Jane Street's CPHI Position: Q3 2026 in Review

Jane Street increased its China Pharma Holdings (CPHI) stake by 156% in Q3 2026, buying an estimated $22.8K and bringing the position to 35,479 shares worth $23.3K. The position accounts for ﹤0.01% of the portfolio, ranked #11248.

Jane Street first reported a position in CPHI in Q4 2018 and has held it in 3 quarters since. 7 funds tracked by Wall St. Rank hold CPHI as of Q3 2026.

Jane Street held 35,479 shares of China Pharma Holdings worth $23.3K as of Q3 2026.
Jane Street bought 21,593 China Pharma Holdings shares in Q3 2026, an estimated $22.8K.
China Pharma Holdings made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #11248 holding.
Jane Street first reported a position in China Pharma Holdings in Q4 2018 and has held it in 3 quarters since.
7 funds tracked by Wall St. Rank held China Pharma Holdings as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.